Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/5/2025

Hyper-IgD Syndrome: Clinical Presentation and Symptoms

Core Clinical Features

  • The American Academy of Allergy, Asthma, and Immunology recommends considering Hyper-IgD syndrome in patients with recurrent febrile attacks accompanied by abdominal pain, joint involvement, lymphadenopathy, and skin lesions, with onset typically in early childhood 1
  • Abdominal complaints, including vomiting, abdominal pain, and diarrhea, occur during attacks, and symptoms can mimic inflammatory bowel disease, particularly Crohn's disease, with associated enlargement of mesenteric lymph nodes 1
  • Joint involvement manifests as arthralgias or frank arthritis during febrile episodes, and skin lesions appear during attacks, with variable morphology 1

Genetic and Diagnostic Considerations

  • The European Society of Human Genetics suggests that Hyper-IgD syndrome is caused by mutations in the MVK gene (mevalonate kinase deficiency), with an autosomal recessive inheritance pattern 1, 2

Management Approach

  • The American College of Rheumatology notes that no definitive cure exists for Hyper-IgD syndrome, and patients experience attacks throughout life, but anti-inflammatory biologicals such as TNF or IL-1 antagonists may be useful, along with corticosteroids 3